Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 251

    Telemedicine startup DocOnline expands its frontiers into Karnataka

    Telemedicine startup DocOnline expands its frontiers into Karnataka

    Ruby Khatun Khatun22 July 2018 10:15 AM IST
    Hyderabad: City-based leading telemedicine startup, DocOnline expanded its frontiers into Karnataka, with the commencement of its operations in...
    Roche gets breakthrough status for Alzheimers test Elecsys

    Roche gets breakthrough status for Alzheimer's test Elecsys

    Ruby Khatun Khatun22 July 2018 9:45 AM IST
    ZURICH: The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer’s disease,...
    Novartis to pay 95 million euros to Galapagos, MorphoSys for skin drug

    Novartis to pay 95 million euros to Galapagos, MorphoSys for skin drug

    Ruby Khatun Khatun22 July 2018 9:30 AM IST
    ZURICH: Novartis said it will pay 95 million euros ($110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin...
    Alembic Pharma gets EIR for Karakhadi facility

    Alembic Pharma gets EIR for Karakhadi facility

    Ruby Khatun Khatun21 July 2018 3:30 PM IST
    New Delhi: Drug firm Alembic Pharmaceuticals said it has received establishment inspection report (EIR) from the US health regulator for its Karakhadi...
    Fortis EGM on 13 August over stake sale to IHH

    Fortis EGM on 13 August over stake sale to IHH

    Ruby Khatun Khatun21 July 2018 10:15 AM IST
    New Delhi: Fortis Healthcare said an extraordinary general meeting (EGM) of the company will be held on 13 August to seek shareholders’ nod for its...
    Madras HC sets up expert body to look into duplicate accident insurance claims

    Madras HC sets up expert body to look into duplicate accident insurance claims

    Ruby Khatun Khatun21 July 2018 10:00 AM IST
    Chennai: Taking a serious view of multiple insurance claims for an accident and involvement of lawyers and touts in the process, the Madras High Court...
    Roche takes Tecentriq hit on survival data

    Roche takes Tecentriq hit on survival data

    Ruby Khatun Khatun21 July 2018 9:45 AM IST
    ZURICH: Roche's hopes of clinching more of the lung cancer treatment market with its Tecentriq immunotherapy had a major setback when a trial failed...
    Merck lowers prices of some drugs after Trump calls out industry

    Merck lowers prices of some drugs after Trump calls out industry

    Ruby Khatun Khatun21 July 2018 9:30 AM IST
    Merck & Co announced price cuts to some of its medicines, including a 60 percent reduction to a hepatitis C treatment, after U.S. President Donald...
    Zydus Cadila gets USFDA approval for arthritis drug

    Zydus Cadila gets USFDA approval for arthritis drug

    Ruby Khatun Khatun20 July 2018 11:45 AM IST
    Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Piroxicam Capsules USP in the...
    Lupin gets USFDA approval for generic erectile dysfunction drug

    Lupin gets USFDA approval for generic erectile dysfunction drug

    Ruby Khatun Khatun20 July 2018 10:45 AM IST
    New Delhi: Drug firm Lupin said it has received tentative approval from the US health regulator for its Tadalafil tablets, indicated for treating...
    Jiva Ayurveda launches first-ever diagnostic protocols for Ayurveda

    Jiva Ayurveda launches first-ever diagnostic protocols for Ayurveda

    Ruby Khatun Khatun20 July 2018 10:00 AM IST
    New Delhi: Jiva Ayurveda, a leading and trusted name in Ayurveda, launched first-of-its-kind diagnostic protocols for Ayurveda with the aim to create...
    Bill Gates backs 30 million dollar push for early Alzheimers diagnostics

    Bill Gates backs 30 million dollar push for early Alzheimer's diagnostics

    Ruby Khatun Khatun20 July 2018 9:45 AM IST
    CHICAGO: Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok